Intraductal @entity5 of the XXXX .

@entity5 @entity1 @entity788 @entity8940
BACKGROUND: Since 1996 the classification of @entity788 was replaced by the new World Health Organization nomenclature. Formerly @entity8940 are now distinguished between intraductal papillary mucinous @entity5 of the @entity788 (IPMT) and @entity8940 . METHODS: We reevaluated the pathological specimen and surgical therapy of 23 consecutive @entity1 and followed up these @entity1 up for 4 years in median. Between 1987 and 1997 we treated 8 @entity1 with IPMT and 15 @entity1 with @entity8940 . RESULTS: Eighty-five per cent of all @entity1 were symptomatic. Ultrasonography and computed tomography were the most sensitive diagnostic techniques. In 25%, the entire @entity788 was involved with IPMT; that was not the case in any of the @entity1 with @entity8940 . All @entity1 were resected with no perioperative mortality. After dismissal from the hospital, all resected @entity1 are still alive after a median follow-up of 4 years. In no @entity1 with IPMT, but in 1 @entity1 with @entity8940 , the @entity5 recurred. CONCLUSION: Surgical resection is the treatment of choice in all @entity5 , and the late outcome of IPMT is as good as for @entity8940 .
